Inflamed immune phenotype predicts favorable clinical outcomes of immune checkpoint inhibitor therapy across multiple cancer types.

Jeanne ShenYoon-La ChoiTaebum LeeHyojin KimYoung Kwang ChaeBen W DulkenStephanie BogdanMaggie HuangGeorge A FisherSehhoon ParkSe-Hoon LeeJun-Eul HwangJin-Haeng ChungLeeseul KimHeon SongSergio PereiraSeunghwan ShinYoojoo LimChang Ho AhnSeulki KimChiyoon OumSukjun KimGahee ParkSanghoon SongWonkyung JungSeokhwi KimYung-Jue BangTony S K MokSiraj M AliChan-Young Ock

Published in: Journal for immunotherapy of cancer (2024)

The AI-based IIP may represent a practical, affordable, clinically actionable, and tumor-agnostic biomarker prognostic of ICI therapy response across diverse tumor types.

Keyphrases

papillary thyroid
artificial intelligence
squamous cell carcinoma
stem cells
mesenchymal stem cells
young adults
cell therapy
deep learning
smoking cessation